KALV logo

KalVista Pharmaceuticals (KALV) Current Assets

Annual Current Assets

$225.69 M
+$53.36 M+30.97%

30 April 2024

KALV Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$191.63 M
-$34.06 M-15.09%

31 July 2024

KALV Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KALV Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+31.0%+49.0%
3 y3 years-14.6%-18.3%
5 y5 years+95.3%+77.6%

KALV Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.6%+31.0%-18.3%+84.1%
5 y5 years-14.6%+154.4%-27.5%+206.6%
alltimeall time-14.6%+4820.2%-27.5%+4348.3%

KalVista Pharmaceuticals Current Assets History

DateAnnualQuarterly
July 2024
-
$191.63 M(-15.1%)
Apr 2024
$9.71 M(-10.7%)
$225.69 M(+116.8%)
Jan 2024
-
$104.10 M(-19.1%)
Oct 2023
-
$128.61 M(-14.2%)
July 2023
-
$149.84 M(-13.0%)
Apr 2023
$10.88 M(+6.3%)
$172.33 M(-10.3%)
Jan 2023
-
$192.13 M(+27.1%)
Oct 2022
-
$151.22 M(-11.3%)
July 2022
-
$170.41 M(-12.0%)
Apr 2022
-
$193.65 M(-9.7%)
Apr 2022
$10.23 M(+32.1%)
-
Jan 2022
-
$214.46 M(-8.5%)
Oct 2021
-
$234.48 M(-6.1%)
July 2021
-
$249.78 M(-5.5%)
Apr 2021
$7.75 M(+102.2%)
$264.26 M(+322.8%)
Jan 2021
-
$62.50 M(-13.3%)
Oct 2020
-
$72.08 M(-10.2%)
July 2020
-
$80.22 M(-9.6%)
Apr 2020
$3.83 M(+48.2%)
$88.70 M(-10.4%)
Jan 2020
-
$99.00 M(-8.2%)
Oct 2019
-
$107.89 M(-6.8%)
July 2019
-
$115.72 M(+0.1%)
DateAnnualQuarterly
Apr 2019
$2.59 M(+28.7%)
$115.55 M(-6.9%)
Jan 2019
-
$124.06 M(-4.6%)
Oct 2018
-
$130.07 M(+135.7%)
July 2018
-
$55.19 M(-7.1%)
Apr 2018
$2.01 M(+1266.7%)
$59.38 M(-9.6%)
Jan 2018
-
$65.71 M(+92.5%)
Oct 2017
-
$34.14 M(+13.1%)
July 2017
-
$30.19 M(-11.7%)
Apr 2017
$147.00 K(+98.6%)
$34.20 M(-9.9%)
Jan 2017
-
$37.95 M(+6.0%)
Sept 2016
-
$35.81 M(-5.6%)
June 2016
-
$37.96 M(-23.3%)
Apr 2016
$74.00 K(-96.0%)
-
Mar 2016
-
$49.47 M(-10.0%)
Dec 2015
$1.85 M(-10.3%)
$54.95 M(-10.6%)
Sept 2015
-
$61.45 M(-8.3%)
June 2015
-
$67.00 M(+1455.1%)
Mar 2015
-
$4.31 M(-6.1%)
Dec 2014
$2.06 M(+954.9%)
$4.59 M(-51.7%)
Sept 2014
-
$9.49 M(-4.3%)
Dec 2013
$195.00 K(-4.4%)
$9.91 M
Dec 2012
$204.00 K
-

FAQ

  • What is KalVista Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals annual current assets year-on-year change?
  • What is KalVista Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for KalVista Pharmaceuticals?
  • What is KalVista Pharmaceuticals quarterly current assets year-on-year change?

What is KalVista Pharmaceuticals annual total current assets?

The current annual current assets of KALV is $225.69 M

What is the all time high annual current assets for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high annual total current assets is $264.26 M

What is KalVista Pharmaceuticals annual current assets year-on-year change?

Over the past year, KALV annual total current assets has changed by +$53.36 M (+30.97%)

What is KalVista Pharmaceuticals quarterly total current assets?

The current quarterly current assets of KALV is $191.63 M

What is the all time high quarterly current assets for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high quarterly total current assets is $264.26 M

What is KalVista Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, KALV quarterly total current assets has changed by +$63.03 M (+49.01%)